Methotrexate Pfizer

Methotrexate, the active ingredient in Methotrexate Pfizer, is an antimetabolite (folate antagonist) presented as a sterile injectable solution for intra‑arterial, intramuscular and intrathecal administration. It is employed to treat autoimmune disorders and certain malignancies in adult and pediatric patients across established distribution networks.

GNH USA supplies Methotrexate Pfizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for complex therapeutic programs and research institutions.

Methotrexate is used in several autoimmune and oncologic disease pathways, providing disease control and symptom relief. - Rheumatoid arthritis: reduces joint inflammation, pain and slows structural damage. - Psoriasis: decreases skin cell proliferation, improving plaque severity. - Acute lymphoblastic leukemia: interferes with malignant cell replication, contributing to remission. - Non‑Hodgkin lymphoma: impedes tumor growth as part of combination chemotherapy. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea and vomiting - Fatigue - Mouth sores (stomatitis) - Elevated liver enzymes - Low blood cell counts (e.g., neutropenia)

Serious or Rare Side Effects: - Pulmonary toxicity (interstitial pneumonitis) - Severe liver injury or fibrosis - Life‑threatening infections due to immunosuppression

Before initiating therapy, several safety considerations should be reviewed. - Pregnancy: contraindicated; teratogenic risk (Category X) - Renal function: assess baseline and monitor; dose adjustment may be needed - Hepatic health: evaluate liver enzymes regularly - Hematologic status: monitor complete blood count for cytopenias - Concomitant drugs: avoid known major interacting agents - Store at controlled room temperature: keep in original container, protect from light and moisture

Methotrexate has notable drug interaction potential that can alter its efficacy or toxicity.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen, naproxen): increase methotrexate toxicity - Penicillins (e.g., ampicillin): reduce renal clearance, raising serum levels - Live vaccines: heightened risk of infection due to immunosuppression

Moderate Interactions (Monitor Closely): - Proton pump inhibitors (e.g., omeprazole): may affect absorption and renal handling - Sulfonamide antibiotics (e.g., trimethoprim‑sulfamethoxazole): can enhance myelosuppression